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Arginine in the FARM and SARM: A Role in Chain-Length
Determination for Arginine in the Aspartate-Rich Motifs of Isoprenyl
Diphosphate Synthases from Mycobacterium tuberculosis
Abstract
Isoprenyl chains are found in many important metabolites. These are derived from precursors of the
appropriate length produced by isoprenyl diphosphate synthases (IDSs). The human pathogen
Mycobacterium tuberculosis makes various isoprenoids/terpenoids, with important roles in their
biosynthesis played by two closely related IDSs, encoded by grcC1 (Rv0562) and grcC2 (Rv0989c), with
Rv0989c generating the 10-carbon precursor (E)-geranyl diphosphate (GPP), and Rv0562 the 20-carbon
precursor (E,E,E)-geranylgeranyl diphosphate (GGPP). Intriguingly, while Rv0562 contains the prototypical
trans-IDS first and second aspartate-rich (DDxxD) motifs (FARM and SARM, respectively), Rv0989c
uniquely contains arginine in place of the second Asp in the FARM and first Asp in the SARM. Here site-
directed mutagenesis of the corresponding residues in both Rv0562 and Rv0989c reveals that these play a role
in determination of product chain length. Specifically, substitution of Asp for the Arg in the FARM and
SARM of Rv0989c leads to increased production of the longer 15-carbon farnesyl diphosphate (FPP), while
substitution of Arg for the corresponding Asp in Rv0562 leads to increased release of shorter products, both
FPP and GPP. Accordingly, while the primary role of the FARM and SARM is known to be chelation of the
divalent magnesium ion co-factors that assist substrate binding and catalysis, the Arg substitutions found in
Rv0989c seem to provide a novel means by which product chain length is moderated, at least in these M.
tuberculosis IDSs.
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Abstract: Isoprenyl chains are found in many important metabolites. These are derived from
precursors of the appropriate length produced by isoprenyl diphosphate synthases (IDSs). The human
pathogen Mycobacterium tuberculosis makes various isoprenoids/terpenoids, with important roles in
their biosynthesis played by two closely related IDSs, encoded by grcC1 (Rv0562) and grcC2 (Rv0989c),
with Rv0989c generating the 10-carbon precursor (E)-geranyl diphosphate (GPP), and Rv0562 the
20-carbon precursor (E,E,E)-geranylgeranyl diphosphate (GGPP). Intriguingly, while Rv0562 contains
the prototypical trans-IDS first and second aspartate-rich (DDxxD) motifs (FARM and SARM,
respectively), Rv0989c uniquely contains arginine in place of the second Asp in the FARM and
first Asp in the SARM. Here site-directed mutagenesis of the corresponding residues in both Rv0562
and Rv0989c reveals that these play a role in determination of product chain length. Specifically,
substitution of Asp for the Arg in the FARM and SARM of Rv0989c leads to increased production of
the longer 15-carbon farnesyl diphosphate (FPP), while substitution of Arg for the corresponding
Asp in Rv0562 leads to increased release of shorter products, both FPP and GPP. Accordingly,
while the primary role of the FARM and SARM is known to be chelation of the divalent magnesium
ion co-factors that assist substrate binding and catalysis, the Arg substitutions found in Rv0989c
seem to provide a novel means by which product chain length is moderated, at least in these
M. tuberculosis IDSs.
Keywords: terpene; isoprenoid; divalent metal co-factor ligation
1. Introduction
Isoprenoids play essential roles in many metabolic pathways. In large part, due to the hydrophobic
nature of polyprenyl chains, these are used to anchor proteins to the membrane or, after cyclization,
form the sterols or hopanoids that are integral membrane molecules. Polyprenol-derived molecules
such as dolichol are essential in the transfer of glycosyl chains from the cytoplasmatic face of the
Endoplasmatic Reticulum (ER) to the ER-lumen where they are attached to proteins, while others
such as quinones are involved in electron transport chains. In addition, short-chain isoprenoids
(≤20-carbons) can be formed into natural products, termed terpenoids, which directly exert various
biological activities [1–3].
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Polymerization of the appropriate length chains from the universal precursors isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) is catalyzed by isoprenyl diphosphate
synthases (IDSs). IDS can be divided on the basis of the double bond configuration, either trans/(E)- or
cis/(Z)-, formed in their prenyl diphosphate products [4]. Shorter chain length prenyl diphosphates
are generally produced by trans-IDS, although there are a few exceptions [5–8]. These short prenyl
diphosphates with trans carbon-carbon double bonds can then be the allylic substrates for cis-IDS
that catalyze further polymerization with IPP and produce long chain prenyl diphosphates such as
decaprenyl diphosphate or undecaprenyl diphosphate, in which the newly added carbon–carbon
double bonds are then in the cis conformation. Although the trans- and cis- IDSs both catalyze similar
reactions, utilizing divalent metal cation co-factors/substrates (usually magnesium, Mg2+) to initiate
ionization of the diphosphate ester bond in their allylic substrate (e.g., DMAPP) that then condenses
with the terminal alkene of IPP followed by proton elimination [9,10], these form two structurally
distinct enzymatic families [4]. For example, while the cis-IDS utilize scattered acidic residues to
coordinate Mg2+, the trans-IDS employ two aspartate-rich DDxxD motifs, simply termed the first
(FARM) and second (SARM), to bind a trio of Mg2+ (Figure 1) [11].
Figure 1. Trans-isoprenyl diphosphate synthase (IDS) reaction mechanism and coordination of substrate
diphosphate moieties in the active site of trans-IDS. (A) The allylic substrate is coordinated by three
Mg2+ co-factors that assist initiating ionization of the diphosphate ester. The resulting carbocation is
attacked by the double bond of isopentenyl diphosphate (IPP), leading to formation of a bond between
the allylic substrate and IPP and a shift of the carbocation. The resulting carbocation is quenched by
deprotonation and formation of a new trans/(E)- double bond in the elongated product. This product
can act as the allylic substrate for further elongation with another IPP molecule. (B) The active site of the
(E,E)-farnesyl diphosphate synthase from E. coli complexed with its substrates IPP and dimethylallyl
diphosphate (DMAPP) (Protein Data Bank (PDB) ID code: 1RIQ). The diphosphate moiety of the allylic
DMAPP is activated by coordination to three Mg2+ that are, in turn, bound by the characteristic first
and second aspartate-rich DDxxD motifs (FARM and SARM), as shown. More specifically, Mg2+A and
Mg2+C are coordinated by the first and last aspartate of the FARM, while Mg2+B is largely coordinated
by the first aspartate of the SARM. By contrast, the diphosphate moiety of IPP is more directly bound
by the basic residues shown. Note that, while the structure contains the thiolo analog of DMAPP,
for illustrative purposes the color of the sulfur was changed to red to resemble that of the oxygen found
in DMAPP.
The human pathogen Mycobacterium tuberculosis encodes an interesting set of IDSs that play
various roles in construction of an array of isoprenoids/terpenoids. These serve key roles in
construction of the complex mycobacterial cell wall. For example, in production of the polyprenyl
phosphate serving as a glyco-carrier required for cell wall biosynthesis [6]. In particular, this 10
isoprenyl-unit carrier is produced via an unusual (Z,E)-farnesyl diphosphate (FPP) intermediate, which
serves as the initial allylic substrate for the long-chain cis-IDS Rv2361c [12]. In turn, the 15-carbon
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(Z,E)-FPP is produced by the short-chain cis-IDS Rv1086, which uses (E)-geranyl diphosphate (GPP) as
its allylic substrate [13]. This unusual bacterial production of the 10-carbon GPP is mediated by the
trans-IDS Rv0989c (grcC2) [14].
An intriguing cell wall lipid that appears to be unique toM. tuberculosis is the diterpenoid (20-carbon)
nucleoside tuberculosinyl-adenosine [15]. This is generated by cyclization of (E,E,E)-geranylgeranyl
diphosphate (GGPP) to tuberculosinyl/halima-5,13E-dienyl diphosphate catalyzed by Rv3377c [16,17],
and subsequent addition of adenosine catalyzed by Rv3378c [18]. A role for this diterpenoid in
suppressing acidification of the phagosomal compartments into which M. tuberculosis are taken up,
which assists infiltration of the engulfing macrophage that then serve as host cells, was indicated by a
genetic screen [19]. Indeed, the diterpenoid itself appears to suppress phagosomal acidification [20].
However, the genetic screen only identified Rv3377c and Rv3378c as essential for this biosynthetic
process [19], and not the trans-IDS GGPP synthase Rv3383c (idsB) found in the same operon [21].
This is presumably due to the presence of an additional trans-IDS that produces the 20-carbon GGPP
in M. tuberculosis, Rv0562 (grcC1) [21].
2. Results
As indicated by their shared genetic nomenclature (i.e., grcC1 and grcC2), Rv0562 and Rv0989c are
closely related (e.g., particularly among the M. tuberculosis IDSs; Figure S1), sharing >56% amino acid
sequence identity, despite their divergent product lengths. A common determinant of product chain
length in trans-IDSs is the identity of the amino acid residue in the fifth position before the FARM [22].
In particular, with smaller residues typically found in GGPP synthases and larger (aromatic) residues
in those trans-IDS with shorter products. However, Rv0562 and Rv0989 both have small residues
at this position (i.e., alanine and glycine, respectively; Figure 2). Thus, there must be an alternative
determinant for the difference in product chain length between these two trans-IDSs.
Figure 2. Partial protein sequence alignment of Rv0989c and Rv0562. Rv0562 contains the canonical
trans-IDS first and second aspartate-rich DDxxD motifs (FARM and SARM; highlighted in green),
but these are both disrupted by Arg substitutions in Rv0989c. The fifth residue upstream of the
FARM, which is typically responsible for product length determination in trans-IDS, is also highlighted
here (orange).
Notably, while Rv0562 contains the canonical DDxxD sequence in both its FARM and SARM,
Rv0989c instead contains arginine in place of the second Asp in its FARM and first Asp in its SARM
(Figure 2). Although Rv0989c also contains an Ala in place of the last Asp of its SARM, this Asp has
been indicated to be less important for trans-IDS activity [23]. Indeed, the M. tuberculosis trans-IDS that
produces (E,E)-FPP, Rv3398c (idsA1) [24], has a Gly at this position. By contrast, all the other Asp in
these motifs have been shown to be important for catalytic activity [4]. Perhaps not surprisingly then,
Arg has not been reported in the FARM or SARM of other trans-IDS. Accordingly, it was hypothesized
that these unique substitutions in Rv0989c might influence product chain length. This was investigated
by iteratively swapping the corresponding active site residues via site-directed mutagenesis between
Rv0989c and the closely related Rv0562.
The resulting mutants were purified and assayed in vitro with DMAPP and IPP. Products were
observed during 30-min assays, indicating that these mutants retain reasonable amounts of catalytic
activity. However, to ensure thorough representation of all synthesized products, the product ratios
reported here are from overnight assays (Table 1). With such extended incubation, wild-type (WT)
Rv0989c produces some (E,E)-FPP unless IPP concentrations are reduced (Table S1). Thus, the product
Molecules 2018, 23, 2546 4 of 7
ratio quantification assays were run with 100 µM DMAPP and 10 µM IPP overnight (Table 1).
Under these conditions, WT Rv0989c produces only GPP, and WT Rv0562 still produces only GGPP.
By contrast, all of the mutants yielded a variety of products. In general, substitution of Asp for the
Arg in Rv0989c led to the production of longer chain product, specifically (E,E)-FPP (but not GGPP),
in addition to GPP. Conversely, substitution of Arg for the corresponding Asp in Rv0562 led to the
appearance of the shorter chain products, both (E,E)-FPP and GPP, with only small amounts of GGPP
produced. With both of these M. tuberculosis trans-IDSs, while the single mutants certainly affect
product outcome, the double-mutant led to the greatest change in product outcome i.e., these exhibit
additive effects.
Table 1. Product profiles of Rv0562, Rv0989c, and associated mutants. Assays were completed
with purified enzyme in the presence of 100 µM DMAPP and 10 µM IPP for 12 hours prior to
dephosphorylation and extraction with organic solvent. Organic extracts were concentrated and
analyzed via GC-FID. Product identity was confirmed via comparison to dephosphorylated authentic
standards prior to integration of peak area. Product profile is represented as percentage of total
isoprenoid peak areas.
Enzyme GPP FPP GGPP
Rv0989c 100 0 0
Rv0989c:R92D 76 24 0
Rv0989c:R217D 40 60 0
Rv0989c:R92D/R217D 30 70 0
Rv0562 0 0 100
Rv0562:D98R 66 34 0
Rv0562:D223R 15 51 34
Rv0562:D98R/D223R 9 90 1
These results indicate that the unique Arg observed in the FARM and SARM of Rv0989c play a
role in the unusual production of the 10-carbon GPP by this M. tuberculosis trans-IDS. This hypothesis
is supported not only by the ability of substituting Asp for these Arg to increase Rv0989c product
chain length, but also the inverse decrease in product chain length observed upon substituting Arg for
the corresponding Asp in the closely related Rv0562 (Table 1). While the second Asp in the FARM does
not typically engage the Mg2+ co-factors, the first Asp in the SARM usually does interact with one of
this trio of divalent metal ions, specifically Mg2+B, to which this Asp provides the major enzymatic
contact [11]. Thus, it seems likely that this Mg2+B is not present in the reactions catalyzed by Rv0989c.
However, the Arg found in the SARM potentially replaces this specific co-factor by directly interacting
with the diphosphate moiety of the allylic substrate (e.g., much like the binding of the diphosphate
moiety of IPP shown in Figure 1). In addition, the Arg found in the FARM presumably shifts this
positioning of this motif, bound Mg2+ and, consequently, also the allylic substrate. Accordingly,
it seems likely that these Arg shift the position of the allylic substrate in a manner that decreases
the available space for the appended isoprenyl chain and, hence, limit the size of the final product.
Regardless, although determination of the exact mechanism will require more detailed structural
analysis, the ability of Arg in the FARM and SARM to affect product chain length, at least in these
M. tuberculosis trans-IDSs, represents a novel means by which such a final product outcome can
be controlled.
3. Materials and Methods
3.1. General Reagents
Unless otherwise indicated, reagents were obtained from Sigma-Aldrich (St. Louis, MO, USA).
Isoprenoid substrates and standards were purchased from Isoprenoids.com (Tampa, FL, USA). Primers
were synthesized by and purchased from Integrated DNA Technologies (Coralville, IA, USA).
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3.2. Sequence Analysis and Alignment
Protein sequences encoded by M. tuberculosis H37Rv loci Rv0562, Rv0989c, Rv1086, Rv2173,
Rv2361c, Rv3383c, and Rv3398c were aligned using the MUSCLE algorithm, with subsequent
phylogenetic analysis using the maximum likelihood method with the JJT frequencies model with
inclusion of a gamma distribution, use of all sites, and 1000 replicates for the bootstrap test, in the
MEGA7 software package [25].
3.3. Site-Directed Mutagenesis
Rv0989c and Rv0562 have previously been cloned, purified, and characterized [14,21].
Site-directed mutagenesis was performed using overlapping mutagenic primers (Figure S2) on
pENTR/SD/D-TOPO constructs of each gene. Final constructs were confirmed via complete
sequencing prior to transfer to pDEST17 vector for protein expression and purification (Invitrogen,
Carlsbad, CA, USA).
3.4. Protein Expression and Assay
Constructs were transformed into Escherichia coli BL21-Star (Invitrogen, Carlsbad, CA, USA)
or C41 OverExpress cells (Lucigen, Middleton, WI, USA). Starter cultures were inoculated into
10 mL NZY media (10 g/L NaCl, 10 g/L casein, 5 g/L yeast extract, 1 g/L MgSO4 (anhydrous),
pH 7.0) with 50 µg/mL carbenicillin and incubated at 200 rpm and 18 ◦C for 3 days. Starter cultures
(5 mL) were used to inoculate 1000 mL fresh NZY media, also with 50 µg/mL carbenicillin, and after
reaching an OD600 of 0.6 they were induced with 1 Mm Isopropyl β-D-1-thiogalactopyranoside
(IPTG) and incubated under continuous shaking at 200 rpm at 18 ◦C for 12 hours. Cells were
harvested by centrifugation at 5000× g for 10 min. The cell pellet was re-suspended in 5 mL 25 mM
3-(N-morpholino)-2-hydroxypropanesulfonic acid buffer (MOPSO), pH 7.2, 10 mM MgCl2, 10% (v/v)
glycerol with 10 mM imidazole, and homogenized using an EmulsiFlex C-5 (Avestin, Canada). The
homogenized suspension was centrifuged at 16,000× g for 60 min. The supernatant was passed
over 1 mL Ni-NTA agarose (Qiagen, Hilden, Germany) washed with 5 mL buffer containing 10 mM
imidazole and an additional 5 mL with 50 mM imidazole. Proteins were eluted with 2 mL buffer
containing 250 mM imidazole.
Enzyme assays were carried out with 300 µg purified protein in 2 mL 25 mM MOPSO, pH 7.2,
10 mM MgCl2, 10% (v/v) glycerol with the addition of 100 µM DMAPP and 10 or 100 µM IPP,
the assays were incubated for either 30 minutes or 24 hours at 30 ◦C before addition of 200 units of
calf intestinal alkaline phosphatase (Promega, Madison, WI) and the supplied buffer. The assay was
dephosphorylated for 24 hours at 30 ◦C and extracted three times with 2 mL pentane. The organic phase
was combined and concentrated under a gentle stream of N2 until a volume of 200 µL solvent remained.
The concentrated organic extracts (1 µL) were injected into 3900 Saturn GC (Varian, Palo Alto, CA) with
an injector temperature of 250 ◦C coupled to a Saturn 2100T ion trap mass spectrometer detector for
product identification. Separation was achieved using a HP-5MS column (30 m × 250 µm × 0.25 µm)
(Agilent, Santa Clara, CA, USA). The chromatographic program was as follows: 50 ◦C for 3 min,
increasing to 300 ◦C by 15 ◦C/min and held at 300 ◦C 3 min. Electrospray ionization scanning from
60–650 m/z was used to obtain product spectra (Figure S3). Quantification of products was completed
using a Shimadzu GC02014 with flame ionization detection (GC-FID) over an SH-Rxi-5ms column
(15 m × 250 µm × 0.25 µm; Shimadzu, Kyoto, Japan) using the previously described method. Products
were confirmed by comparison, of both retention time and mass spectra (Figure S3), to isoprenoid
diphosphate authentic standards dephosphorylated as above.
Supplementary Materials: Supplementary materials are available on line.
Author Contributions: F.M.M. and R.J.P. conceived the research and wrote the manuscript; R.N., F.M.M., J.A.T.
and F.A.A. performed research, analyzed data and revised the manuscript.
Molecules 2018, 23, 2546 6 of 7
Funding: This work was supported by a grant from the NIH (GM076324) to R.J.P. and a postdoctoral fellowship
to R.N. from the Deutsche Forschungsgemeinschaft (DFG) NA 1261/1-2.
Acknowledgments: The authors thank Meimei Xu for assistance with constructing mutants and expression
vectors.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Gershenzon, J.; Dudareva, N. The function of terpene natural products in the natural world. Nat. Chem. Biol.
2007, 3, 408–414. [CrossRef] [PubMed]
2. Pichersky, E.; Raguso, R.A. Why do plants produce so many terpenoid compounds? New Phytol. 2016.
[CrossRef] [PubMed]
3. Buckingham, J. Dictionary of Natural Products (on-line web edition); Chapman & Hall/CRC Press: London,
UK, 2007.
4. Liang, P.-H.; Ko, T.-P.; Wang, A.H.-J. Structure, mechanism and function of prenyltransferases. Eur. J. Biochem.
2002, 269, 3339–3354. [CrossRef] [PubMed]
5. Chen, A.P.; Chang, S.Y.; Lin, Y.C.; Sun, Y.S.; Chen, C.T.; Wang, A.H.; Liang, P.H. Substrate and product
specificities of cis-type undecaprenyl pyrophosphate synthase. Biochem. J. 2005, 386, 169–176. [CrossRef]
[PubMed]
6. Kaur, D.; Brennan, P.J.; Crick, D.C. Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis.
J. Bacteriol. 2004, 186, 7564–7570. [CrossRef] [PubMed]
7. Swiezewska, E.; Danikiewicz, W. Polyisoprenoids: Structure, biosynthesis and function. Prog. Lipid Res.
2005, 44, 235–258. [CrossRef] [PubMed]
8. Akhtar, T.A.; Matsuba, Y.; Schauvinhold, I.; Yu, G.; Lees, H.A.; Klein, S.E.; Pichersky, E. The tomato
cisprenyltransferase gene family. Plant J. 2013, 73, 640–652. [CrossRef] [PubMed]
9. Poulter, C.D.; Rilling, H.C. Prenyltransferase: the mechanism of the reaction. Biochemistry 1976, 15, 1079–1083.
[CrossRef] [PubMed]
10. Poulter, C.D.; Satterwhite, D.M.; Rilling, H.C. Prenyltransferase—Mechanism Of Reaction. J. Am. Chem. Soc.
1976, 98, 3376–3377. [CrossRef] [PubMed]
11. Aaron, J.A.; Christianson, D.W. Trinuclear Metal Clusters in Catalysis by Terpenoid Synthases. Pure Appl.
Chem. 2010, 82, 1585–1597. [CrossRef] [PubMed]
12. Schulbach, M.C.; Brennan, P.J.; Crick, D.C. Identification of a Short (C15) ChainZ-Isoprenyl Diphosphate
Synthase and a Homologous Long (C50) Chain Isoprenyl Diphosphate Synthase inMycobacterium
tuberculosis. J. Biol. Chem. 2000, 275, 22876–22881. [CrossRef] [PubMed]
13. Schulbach, M.C.; Mahapatra, S.; Macchia, M.; Barontini, S.; Papi, C.; Minutolo, F.; Bertini, S.; Brennan, P.J.;
Crick, D.C. Purification, Enzymatic Characterization, and Inhibition of theZ-Farnesyl Diphosphate Synthase
from Mycobacterium tuberculosis. J. Biol. Chem. 2001, 276, 11624–11630. [CrossRef] [PubMed]
14. Mann, F.M.; Thomas, J.A.; Peters, R.J. Rv0989c encodes a novel (E)-geranyl diphosphate synthase facilitating
decaprenyl diphosphate biosynthesis in Mycobacterium tuberculosis. FEBS Lett. 2011, 585, 549–554.
[CrossRef] [PubMed]
15. Young, D.; Moody, D. In vivo biosynthesis of terpene nucleosides provides unique chemical markers of
Mycobacterium tuberculosis infection. Chem. Bio. 2015, 22, 516–526. [CrossRef] [PubMed]
16. Mann, F.M.; Prisic, S.; Hu, H.; Xu, M.; Coates, R.M.; Peters, R.J. Characterization and inhibition of a class II
diterpene cyclase from Mycobacterium tuberculosis: implications for tuberculosis. J. Biol. Chem. 2009, 284,
23574–23579. [CrossRef] [PubMed]
17. Nakano, C.; Hoshino, T. Characterization of the Rv3377c gene product, a type-B diterpene cyclase, from the
Mycobacterium tuberculosis H37 genome. Chembiochem 2009, 10, 2060–2071. [CrossRef] [PubMed]
18. Layre, E.; Lee, H.J.; Young, D.C.; Martinot, A.J.; Buter, J.; Minnaard, A.J.; Annand, J.W.; Fortune, S.M.;
Snider, B.B. Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products
of the virulence-associated enzyme Rv3378c. Proc. National Acad. Sci. 2014, 111, 2978–2983. [CrossRef]
[PubMed]
Molecules 2018, 23, 2546 7 of 7
19. Pethe, K.; Swenson, D.L.; Alonso, S.; Anderson, J.; Wang, C.; Russell, D.G. Isolation of Mycobacterium
tuberculosis mutants defective in the arrest of phagosome maturation. Proc. National Acad. Sci. 2004, 101,
13642–13647. [CrossRef] [PubMed]
20. Mann, F.M.; Xu, M.; Chen, X.; Fulton, D.B.; Russell, D.G.; Peters, R.J. Edaxadiene: A new bioactive diterpene
from Mycobacterium tuberculosis. J. Am. Chem. Soc. 2009, 131, 15726–15727. [CrossRef] [PubMed]
21. Mann, F.M.; Xu, M.; Davenport, E.K.; Peters, R.J. Functional characterization and evolution of the
isotuberculosinol operon in Mycobacterium tuberculosis and related Mycobacteria. Front Microbiol. 2012, 3,
368. [CrossRef] [PubMed]
22. Ohnuma, S.; Narita, K.; Nakazawa, T.; Ishida, C.; Takeuchi, C.; Ohto, C.; Nishino, T. A role of the amino acid
residue located on the fifth position before the first aspartate-rich motif of farnesyl diphosphate synthase on
determination of the final product. J. Biol. Chem. 1996, 271, 30748–30754. [CrossRef] [PubMed]
23. Joly, A.; Edwards, P.A. Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon
farnesyl diphosphate synthase activity. J. Biol. Chem. 1993, 268, 26983–26989. [PubMed]
24. Dhiman, R.K.; Schulbach, M.C.; Mahapatra, S.; Baulard, A.R.; Vissa, V.; Brennan, P.J.; Crick, D.C. Identification
of a novel class of omega,E,E-farnesyl diphosphate synthase from Mycobacterium tuberculosis. J. Lipid Res.
2004, 45, 1140–1147. [CrossRef] [PubMed]
25. Kumar, S.; Stecher, G.; Tamura, K. MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger
Datasets. Mol. Biol. Evol. 2016, 33, 1870–1874. [CrossRef] [PubMed]
Sample Availability: Samples of the compounds (plasmids) are available from the authors, while the isoprenoids
are commercially available.
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
